Parallax Volatility Advisers, L.P. Clovis Oncology, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

1 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $864,600 - $3.38 Million	220,000 New	220,000 $864,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.